1-20 of 192
Marek Trneny
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)

Laurie H. Sehn, Stefano Luminari, Christian W. Scholz, Kai Hübel, Antonio Salar, Shankara Paneesha, Bjorn E Wahlin, Panayiotis Panayiotidis, Hui-Peng Lee, Ana Jiménez Ubieto, Juan-Manuel Sancho, Tae Min Kim, Eva Domingo Domenech, Takahiro Kumode, Christina Poh, Catherine Thieblemont, Dries Deeren, Edwin de Wit, Michael Arbushites, Marie-Laure Casadebaig, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 2): LBA-1.
https://doi.org/10.1182/blood-2024-212970
Published: 2024
Journal Articles

Circulating Tumor DNA As a Predictor of Survival of DLBCL Patients in a Daily Practice

Iva Hamova, Prokop Vodicka, Adriana Velasova, Kristyna Kupcova, Petra Zemankova, Petr Nehasil, Anton Tkachenko, Kamila Polgarova, Jana Salkova, Katerina Benesova, Pavel Klener, Marek Trneny, Ondrej Havranek
Journal: Blood
Blood (2024) 144 (Supplement 1): 6235.
https://doi.org/10.1182/blood-2024-211263
Published: 2024
Journal Articles

Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes

Gilles Salles, Franck Morschhauser, Laurie H. Sehn, Alex F. Herrera, Jonathan W. Friedberg, Marek Trněný, Georg Lenz, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Graham P. Collins, Yuqin Song, Antonio Pinto, Shinya Rai, Koji Izutsu, Calvin Lee, Saibah Chohan, Matthew Sugidono, Yanwen Jiang, Connie Lee Batlevi, Mark Yan, Jamie Hirata, Hervé Tilly, Christopher R. Flowers
Journal: Blood
Blood (2024) 144 (Supplement 1): 469.
https://doi.org/10.1182/blood-2024-197938
Published: 2024
Journal Articles

Hematopoietic Stem Cell Transplantation for Marginal Zone Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Yasmina I.M. Serroukh, Mathilde Fekom, Irma Khvedelidze, Ben Carpenter, Herve Ghesquieres, Ludovic Gabellier, Jacques-Olivier Bay, Didier Blaise, Maurizio Musso, Patrice Chevallier, Edouard Forcade, Anne Huynh, Andy Peniket, Marek Trněný, Catherine Flynn, Shankara Paneesha, Andrew Clark, Charalampia Kyriakou, Anna Ossami Saidy, Bertram Glass, Luca Castagna, Silvia Montoto, Ali Bazarbachi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3027.
https://doi.org/10.1182/blood-2024-194632
Published: 2024
Journal Articles

The Survival Improvement of Transplant-Eligible Primary CNS Lymphoma Patients within Last 15 Years

Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Andrea Hruskova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Alice Sykorova, Michal Masar, Jitka Dlouha, Petra Blahovcova, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1697.
https://doi.org/10.1182/blood-2024-208416
Published: 2024
Journal Articles

BMI and Its Changes As a Predictor of Survival in DLBCL Patients

Michal Masar, Prokop Vodicka, Magdalena Klanova, Kamila Polgarova, Katerina Benesova, Diana Malarikova, Jana Salkova, Jan Koren, Pavel Klener, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1713.
https://doi.org/10.1182/blood-2024-208542
Published: 2024
Journal Articles

PCNSL Patients Treated with the Matrix Regimen in the Real World Have Similar Outcome to Those in the IELSG 32 Trial

Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Veronika Hanackova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Eva Konirova, Tomas Prochazka, Kamila Polgarova, Jitka Dlouha, Petra Blahovcova, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1711.
https://doi.org/10.1182/blood-2024-204795
Published: 2024
Journal Articles

Glofitamab Induces High Response Rates and Durable Remissions in Patients (Pts) with Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL), Including Those with a Poor Prognosis: Subgroup Results from a Phase I/II Study

Tycel J. Phillips, Marek Trněný, Carmelo Carlo-Stella, Jan Maciej Zaucha, Tomasz Wrobel, Fritz Offner, Michael J. Dickinson, Monica Tani, Michael Crump, Nancy L. Bartlett, Joaquín Martínez-Lopez, Paolo Corradini, Estefania Mulvihill, Alessia Bottos, Derrick Kaufman, James Relf, Fabiola Bene Tchaleu, Alexandra Bazeos, Linda Lundberg, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 1631.
https://doi.org/10.1182/blood-2024-200018
Published: 2024
Journal Articles

Fixed-Duration Glofitamab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-up from a Pivotal Phase II Study

Michael J. Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Guillaume Cartron, Paolo Corradini, Nancy L. Bartlett, Gloria Iacoboni, Cyrus Khan, Mark S. Hertzberg, Lorenzo Falchi, Joshua Brody, Marek Trněný, Estefania Mulvihill, Aurelien Berthier, Alessia Bottos, James Relf, Fabiola Bene Tchaleu, Linda Lundberg, Martin Hutchings
Journal: Blood
Blood (2024) 144 (Supplement 1): 865.
https://doi.org/10.1182/blood-2024-194333
Published: 2024
Journal Articles

Vitreous Body Cell Free DNA Sequencing As a Reliable Method for Vitreoretinal Lymphoma Diagnostics

Adriana Velasova, Lucie Dlouha, Iva Hamova, Kristyna Kupcova, Petra Zemankova, Petr Nehasil, Jana Senavova, Katerina Benesova, Petra Svozilkova, Jarmila Heissigerova, Marek Trneny, Ondrej Havranek
Journal: Blood
Blood (2024) 144 (Supplement 1): 2979.
https://doi.org/10.1182/blood-2024-211732
Published: 2024
Journal Articles

Validation of the CNS-IPI-C Prognostic Model in Patients with Systemic DLBCL in the Real World

Michal Masar, Prokop Vodicka, Samuel Hricko, Andrea Janikova, Katerina Benesova, David Salek, Jana Salkova, Martina Filipova, Jan Galko, Vit Campr, Magdalena Klanova, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 3081.
https://doi.org/10.1182/blood-2024-208592
Published: 2024
Journal Articles

Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?

Liliana Tuskova, Diana Maláriková, Katerina Benesova, Eva Konirova, Kamila Polgarova, Petra Blahovcova, Jana Salkova, Marek Trněný, Pavel Klener
Journal: Blood
Blood (2024) 144 (Supplement 1): 3012.
https://doi.org/10.1182/blood-2024-198865
Published: 2024
Journal Articles

Comprehensive Genomic Analysis of Non-Relapsed and Late-Relapsed Mantle Cell Lymphoma Patients Compared to Refractory and Early-Relapsed Patients Treated By Standard Immunochemotherapy

Jana Karolova, Dmitry Kazantsev, Lucie Winkowska, Kristina Forsterova, Liliana Tuskova, Diana Malarikova, Veronika Valkova, Andrea Janikova, Ales Obr, Marek Trneny, Pavel Klener
Journal: Blood
Blood (2024) 144 (Supplement 1): 2973.
https://doi.org/10.1182/blood-2024-198876
Published: 2024
Journal Articles

Outcome of Hematopoietic Stem Cell Transplantation for Follicular Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Yasmina I.M. Serroukh, Mathilde Fekom, Irma Khvedelidze, Ben Carpenter, Herve Ghesquieres, Ludovic Gabellier, Jacques-Olivier Bay, Didier Blaise, Maurizio Musso, Patrice Chevallier, Edouard Forcade, Anne Huynh, Andy Peniket, Marek Trněný, Catherine Flynn, Shankara Paneesha, Andrew Clark, Charalampia Kyriakou, Anna Ossami Saidy, Bertram Glass, Luca Castagna, Silvia Montoto, Ali Bazarbachi
Journal: Blood
Blood (2024) 144 (Supplement 1): 749.
https://doi.org/10.1182/blood-2024-194657
Published: 2024
Journal Articles

Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

Martin Dreyling, Jeanette K Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke KJ Vergote, Daniela Donnarumma, Ofer Shpilberg, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster
Journal: Blood
Blood (2024) 144 (Supplement 1): 240.
https://doi.org/10.1182/blood-2024-200735
Published: 2024
Journal Articles

Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project

Marco Ladetto, Katja Gutmair, Jeanette K Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke KJ Vergote, Piero Maria Stefani, Netanel A. Horowitz, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Christian Schmidt, Michael Unterhalt, Martin Dreyling, Eva Hoster
Journal: Blood
Blood (2024) 144 (Supplement 1): 237.
https://doi.org/10.1182/blood-2024-201441
Published: 2024
Journal Articles

A Murine Phase 2 Proof-of-Concept Study of Polatuzumab Vedotin in Combination with Venetoclax in Experimental Therapy of BCL2-Positive Aggressive Lymphomas

Dmitry Kazantsev, Eva Pokorna, Kristýna Nožičková, Alexandra Dolníková, Nicol Renešová, Liliana Tuskova, Marek Trněný, Pavel Klener
Journal: Blood
Blood (2024) 144 (Supplement 1): 974.
https://doi.org/10.1182/blood-2024-194588
Published: 2024
Journal Articles

Trials in Progress: Carman - an International, Randomized Phase II Study Evaluating Early Treatment Intensification in Patients with High Risk Mantle Cell Lymphoma Using CAR-T-Cell Treatment after an Abbreviated Induction Therapy with Rituximab and Ibrutinib and 6 Months Ibrutinib Maintenance (Arm A) As Compared to Standard of Care Induction and Maintenance (Arm B)

Marie-Kristin Tilch, Christian Schmidt, Marek Trneny, Eva Gine, Olivier Hermine, Anke Ohler, Stephanie Herold, Marta Illenyi, Eva Hoster, Christiane Pott, Martin Dreyling, Georg Hess
Journal: Blood
Blood (2024) 144 (Supplement 1): 4422.3.
https://doi.org/10.1182/blood-2024-206931
Published: 2024
Journal Articles

Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study

Michael Wang, Wojciech Jurczak, Marek Trněný, David Belada, Tomasz Wrobel, Nilanjan Ghosh, Mary-Margaret Keating, Tom van Meerten, Ruben Fernandez Alvarez, Gottfried von Keudell, Catherine Thieblemont, Frederic Peyrade, Marc Andre, Marc Hoffmann, Edith Szafer Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam
Journal: Blood
Blood (2023) 142 (Supplement 2): LBA-2.
https://doi.org/10.1182/blood-2023-191921
Published: 2023
Journal Articles

Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?

Magdalena Klanova, Samuel Hricko, Michal Masar, David Salek, Prokop Vodicka, Natasa Kopalova, Petra Blahovcova, Katerina Benesova, Jozef Michalka, Jan Koren, Andrea Janikova, Marek Trneny
Journal: Blood
Blood (2023) 142 (Supplement 1): 4479.
https://doi.org/10.1182/blood-2023-178208
Published: 2023